▶︎ Journal of Atherosclerosis and Thrombosis
——————————
Reviews
——————————
Current Diagnosis and Management of Primary Chylomicronemia
Hiroaki Okazaki, et al., J Atheroscler Thromb, 2021; 28: 883-904.
Cerebrotendinous Xanthomatosis: Molecular Pathogenesis, Clinical Spectrum, Diagnosis, and Disease-Modifying Treatments
Shingo Koyama, et al., J Atheroscler Thromb, 2021; 28: 905-925.
——————————
Editorials
——————————
Reduced Renal Function and Stroke Subtypes
Yuji Shimizu, J Atheroscler Thromb, 2021; 28: 926-927.
——————————
Original Articles
——————————
Reduced Glomerular Filtration Rate and Risk of Stroke: A Nationwide Cohort Study in South Korea
Chang-Mo Oh, et al., J Atheroscler Thromb, 2021; 28: 928-941.
Relationships between Smoking Status, Cardiovascular Risk Factors, and Lipoproteins in a Large Japanese Population
Marie Nakamura, et al., J Atheroscler Thromb, 2021; 28: 942-953.
Outcomes of Dissection Angles as Predictor of Restenosis after Drug-Coated Balloon Treatment
Amane Kozuki, et al., J Atheroscler Thromb, 2021; 28: 954-962.
Volume Elastic Modulus, Vascular Function, and Vascular Structure in Patients with Cardiovascular Risk Factors
Tatsuya Maruhashi, et al., J Atheroscler Thromb, 2021; 28: 963-973.
Distinct Differences in Lipoprotein Particle Number Evaluation between GP-HPLC and NMR: Analysis in Dyslipidemic Patients Administered a Selective PPARα Modulator, Pemafibrate
Shizuya Yamashita, et al., J Atheroscler Thromb, 2021; 28: 974-996.
The Predictive Values of Different Small Vessel Disease Scores on Clinical Outcomes in Mild ICH Patients
Tianqi Xu, et al., J Atheroscler Thromb, 2021; 28: 997-1008.